Physician profile
Shelly Russo
NPI 1104549187
$836.65
in general payments reported to CMS, 2019-2025
10 companies · $650 in 2025
The $650 reported for 2025 was more than what 78% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $60.81 · 2024: $126 · 2025: $650.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $837.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $836.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $399.20 | 2023-2025 | Acticor 7 Vr-T Dx, Biomonitor, Sentus |
| Boston Scientific Corporation | $133.24 | 2024-2025 | Watchman Access System, Latitude Communicator Power Supply |
| Pfizer INC. | $73.71 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $53.40 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $46.51 | 2024-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $42.59 | 2025 | Verquvo |
| Amgen INC. | $29.22 | 2025 | Repatha |
| Scpharmaceuticals INC. | $23.47 | 2025 | |
| Vital Connect, INC | $18.85 | 2025 | Vitalpatch Rtm |
| Novartis Pharmaceuticals Corporation | $16.46 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shelly Russo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.